According to the latest report by IMARC Group, titled “Cerebral Oximetry Monitoring Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global cerebral oximetry monitoring market size reached US$ 78.4 Million in 2022. Cerebral oximetry monitoring refers to a non-invasive medical technique used to measure oxygen saturation levels in the brain. It involves the utilization of near-infrared (IR) light to penetrate the tissues of the head and detect the amount of oxygenated and deoxygenated hemoglobin. It is widely used for anesthesia management, cardiac surgery, critical care, clinical trials, neonatal care, and monitoring neurological conditions, such as stroke, traumatic brain injury (TBI), and intracranial hemorrhage. Cerebral oximetry monitoring is a highly efficient and user-friendly technique that provides real-time measurement capabilities, increases patient safety, assists in treatment optimization, improves clinical outcomes, and enables early detection of compromised brain oxygenation.
Cerebral Oximetry Monitoring Market Trends:
The growing prevalence of neurological disorders is one of the primary factors propelling the market growth. Cerebral oximetry monitoring is widely used to assess the extent of brain injury, guide treatment decisions, address oxygen demand-supply imbalances, and monitor the response to various interventions. In addition to this, the rising emphasis on patient safety and prevention of adverse neurological complications is acting as another growth-inducing factor. Furthermore, the increasing number of surgical and critical care procedures is facilitating the demand for cerebral oximetry monitoring to minimize the risk of cerebral hypoxia and assist healthcare professionals in monitoring the patient’s condition. Additionally, the introduction of wireless and wearable cerebral oximetry systems that enhance patient mobility, increase comfort, and enable real-time data transmission to monitoring systems is positively influencing the market growth. Moreover, the implementation of supportive government policies to improve healthcare infrastructure, enhance patient safety, and provide access to high-quality treatment facilities are contributing to the market growth. Other factors, including rising geriatric population, increasing investment in the research and development (R&D) of advanced cerebral oximeters, and growing demand for minimally invasive (MI) monitoring techniques, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 119.78 Million by 2028, exhibiting a CAGR of 7.10% during 2023-2028.
- On the basis of the age, the market has been bifurcated into adult and pediatrics.
- Based on the application, the market has been classified into cardiac and vascular surgery.
- On the basis of the end use, the market has been bifurcated into hospital and clinic. Among these, hospitals represent the largest segment.
- On a regional basis, the market has been categorized into North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Among these, North America holds the largest market for cerebral oximetry monitoring.
- The competitive landscape of the industry has also been examined, with some of the key players being Edwards Lifesciences, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Nonin Medical Inc, etc.
|Base Year of the Analysis
||Cardiac Surgery, Vascular Surgery
|End Uses Covered
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Edwards Lifesciences, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Nonin Medical Inc, etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800